+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Relaxin Ameliorates Renal Fibrosis and Expression of Endothelial Cell Transition Markers in Rats of Isoproterenol-Induced Heart Failure

Relaxin Ameliorates Renal Fibrosis and Expression of Endothelial Cell Transition Markers in Rats of Isoproterenol-Induced Heart Failure

Biological and Pharmaceutical Bulletin 40(7): 960-966

There may be cardio-renal interactions in rats of isoproterenol-induced heart failure, which may be associated with renal fibrosis and endothelial-to-mesenchymal transition (EndMT). Since its discovery, relaxin (RLX) which was regarded as a reproductive hormone for a long time, is recently considered an effective antifibrotic hormone in cardiac and renal fibrosis. We studied whether RLX diminished renal fibrosis in rats of isoproterenol (Iso)-induced heart failure and investigated the mechanism. Fifty male Sprague-Dawley rats were separated into five groups for treatment: control; Iso subcutaneously injection to induce heart failure, which led to renal fibrosis; RLX subcutaneously injection at low, medium and high dose (0.2, 2, 20 µg·kg-1·d-1 for 21 d). Indices of cardiac function and organ fibrosis were examined. Expression and changes in levels of collagen, cluster of differentiation 31 (CD31), α-smooth muscle actin (SMA), and transforming growth factor β (TGF-β) were measured in renal tissues. In rats with heart failure induced by Iso, treatment with RLX significantly ameliorated cardiac function and inhibited cardiac and renal fibrosis. RLX decreased renal collagen types I and III deposition, increased CD31 expression, and decreased the expression of α-SMA and TGF-β, thereby possibly indicating inhibited renal EndMT in kidneys. Iso-induced heart and renal fibrosis was inhibited even greater with high-dose RLX, so the antifibrotic effect of RLX may be dose-related. In conclusion, RLX may ameliorate renal fibrosis in rats of Iso-induced heart failure, and it is infered that prevention of the EndMT may be one of the possible potential signaling pathways.

Please choose payment method:

(PDF emailed within 0-6 h: $19.90)

Accession: 060190646

Download citation: RISBibTeXText

PMID: 28674260

DOI: 10.1248/bpb.b16-00882

Related references

Paricalcitol Attenuates Cardiac Fibrosis and Expression of Endothelial Cell Transition Markers in Isoproterenol-Induced Cardiomyopathic Rats. Critical Care Medicine 44(9): E866-E874, 2017

Spirolactone provides protection from renal fibrosis by inhibiting the endothelial-mesenchymal transition in isoprenaline-induced heart failure in rats. Drug Design, Development and Therapy 10: 1581-1588, 2017

Effects of renal denervation on left atrial fibrosis in rats with isoproterenol induced chronic heart failure. Zhonghua Xin Xue Guan Bing Za Zhi 43(12): 1040-1045, 2016

Anti-Fibrosis Effect of Relaxin and Spironolactone Combined on Isoprenaline-Induced Myocardial Fibrosis in Rats via Inhibition of Endothelial-Mesenchymal Transition. Cellular Physiology and Biochemistry 41(3): 1167-1178, 2017

Natakalim Ameliorates Isoproterenol-Induced Chronic Heart Failure by Protecting against Endothelial Dysfunction. Pharmacology 98(3-4): 99-110, 2017

Bilateral Renal Denervation Ameliorates Isoproterenol-Induced Heart Failure through Downregulation of the Brain Renin-Angiotensin System and Inflammation in Rat. Oxidative Medicine and Cellular Longevity 2016: 3562634, 2017

Renal sympathetic denervation alleviates myocardial fibrosis following isoproterenol-induced heart failure. Molecular Medicine Reports 16(4): 5091-5098, 2017

Ginsenoside Re Improves Isoproterenol-Induced Myocardial Fibrosis and Heart Failure in Rats. Evidence-Based Complementary and Alternative Medicine 2019: 3714508, 2019

L-arginine administration ameliorates cardiac dysfunction, but does not affect hypertrophy and further downregulates MYH6 expression in isoproterenol-induced heart failure. European Heart Journal 34(Suppl 1): P3336-P3336, 2013

Mesenchymal stem cell transplantation attenuates cardiac fibrosis associated with isoproterenol-induced global heart failure. Transplant International 21(12): 1181-1189, 2008

Cinacalcet attenuates the renal endothelial-to-mesenchymal transition in rats with adenine-induced renal failure. American Journal of Physiology. Renal Physiology 306(1): F138-F146, 2014

Increased expression of myocardial semaphorin 3A in isoproterenol-induced heart failure rats. Chinese Medical Journal 124(14): 2173-2178, 2012

Fenofibrate Modulates HO-1 and Ameliorates Endothelial Expression of Cell Adhesion Molecules in Systolic Heart Failure. Acta Cardiologica Sinica 29(3): 251-260, 2013

Relaxin Family Member Insulin-Like Peptide 6 Ameliorates Cardiac Fibrosis and Prevents Cardiac Remodeling in Murine Heart Failure Models. Journal of the American Heart Association 7(12), 2018

Evodiamine Prevents Isoproterenol-Induced Cardiac Fibrosis by Regulating Endothelial-to-Mesenchymal Transition. Planta Medica 83(9): 761-769, 2016